Selected research
Industry Research
Pharmaceutical Microbiology Rapid Testing Industry Research Report 2026
Market perspective
The global Pharmaceutical Microbiology Rapid Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Microbiology Rapid Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Microbiology Rapid Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Microbiology Rapid Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Microbiology Rapid Testing include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U. (Zendal Health S.A.) and Indian Immunologicals Ltd. (National Dairy Development Board) and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Microbiology Rapid Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Microbiology Rapid Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Microbiology Rapid Testing Market by Company
Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U. (Zendal Health S.A.)
Indian Immunologicals Ltd. (National Dairy Development Board)
Vaxxinova International BV (EW Group)
Pharmaceutical Microbiology Rapid Testing Segment by Type
Instruments
Reagents & Kits
Consumables
Pharmaceutical Microbiology Rapid Testing Segment by Application
Biopharmaceutical Company
Hospital
Others
Pharmaceutical Microbiology Rapid Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Microbiology Rapid Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Microbiology Rapid Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Microbiology Rapid Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Microbiology Rapid Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Reagents & Kits
- Consumables
Applications
- Biopharmaceutical Company
- Hospital
- Others
Companies covered
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- Merck & Co., Inc.
- Bimeda, Inc.
- Elanco Animal Health, Inc.
- Virbac
- Ceva Sante Animale
- CZ Vaccines S.A.U. (Zendal Health S.A.)
- Indian Immunologicals Ltd. (National Dairy Development Board)
- Vaxxinova International BV (EW Group)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Microbiology Rapid Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Instruments
- 2.2.3 Reagents & Kits
- 2.2.4 Consumables
- 2.3 Pharmaceutical Microbiology Rapid Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Company
- 2.3.3 Hospital
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Pharmaceutical Microbiology Rapid Testing Breakdown Data by Type
- 3.1 Global Pharmaceutical Microbiology Rapid Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Microbiology Rapid Testing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Microbiology Rapid Testing Breakdown Data by Application
- 4.1 Global Pharmaceutical Microbiology Rapid Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Microbiology Rapid Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Microbiology Rapid Testing Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Microbiology Rapid Testing Growth Trends by Region
- 5.2.1 Global Pharmaceutical Microbiology Rapid Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Microbiology Rapid Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Microbiology Rapid Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Microbiology Rapid Testing Market Dynamics
- 5.3.1 Pharmaceutical Microbiology Rapid Testing Industry Trends
- 5.3.2 Pharmaceutical Microbiology Rapid Testing Market Drivers
- 5.3.3 Pharmaceutical Microbiology Rapid Testing Market Challenges
- 5.3.4 Pharmaceutical Microbiology Rapid Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Microbiology Rapid Testing Players by Revenue
- 6.1.1 Global Top Pharmaceutical Microbiology Rapid Testing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Microbiology Rapid Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Microbiology Rapid Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Microbiology Rapid Testing Head Office and Area Served
- 6.4 Global Pharmaceutical Microbiology Rapid Testing Players, Product Type & Application
- 6.5 Global Pharmaceutical Microbiology Rapid Testing Manufacturers Established Date
- 6.6 Global Pharmaceutical Microbiology Rapid Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032)
- 7.2 North America Pharmaceutical Microbiology Rapid Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Microbiology Rapid Testing Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Microbiology Rapid Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Microbiology Rapid Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Microbiology Rapid Testing Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Microbiology Rapid Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Microbiology Rapid Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Microbiology Rapid Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Microbiology Rapid Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032)
- 10.2 South America Pharmaceutical Microbiology Rapid Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Microbiology Rapid Testing Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Microbiology Rapid Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Microbiology Rapid Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Microbiology Rapid Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Microbiology Rapid Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Boehringer Ingelheim International GmbH
- 12.1.1 Boehringer Ingelheim International GmbH Company Information
- 12.1.2 Boehringer Ingelheim International GmbH Business Overview
- 12.1.3 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.1.4 Boehringer Ingelheim International GmbH Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.1.5 Boehringer Ingelheim International GmbH Recent Developments
- 12.2 Zoetis, Inc.
- 12.2.1 Zoetis, Inc. Company Information
- 12.2.2 Zoetis, Inc. Business Overview
- 12.2.3 Zoetis, Inc. Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.2.4 Zoetis, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.2.5 Zoetis, Inc. Recent Developments
- 12.3 Merck & Co., Inc.
- 12.3.1 Merck & Co., Inc. Company Information
- 12.3.2 Merck & Co., Inc. Business Overview
- 12.3.3 Merck & Co., Inc. Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.3.4 Merck & Co., Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.3.5 Merck & Co., Inc. Recent Developments
- 12.4 Bimeda, Inc.
- 12.4.1 Bimeda, Inc. Company Information
- 12.4.2 Bimeda, Inc. Business Overview
- 12.4.3 Bimeda, Inc. Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.4.4 Bimeda, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.4.5 Bimeda, Inc. Recent Developments
- 12.5 Elanco Animal Health, Inc.
- 12.5.1 Elanco Animal Health, Inc. Company Information
- 12.5.2 Elanco Animal Health, Inc. Business Overview
- 12.5.3 Elanco Animal Health, Inc. Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.5.4 Elanco Animal Health, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.5.5 Elanco Animal Health, Inc. Recent Developments
- 12.6 Virbac
- 12.6.1 Virbac Company Information
- 12.6.2 Virbac Business Overview
- 12.6.3 Virbac Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.6.4 Virbac Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.6.5 Virbac Recent Developments
- 12.7 Ceva Sante Animale
- 12.7.1 Ceva Sante Animale Company Information
- 12.7.2 Ceva Sante Animale Business Overview
- 12.7.3 Ceva Sante Animale Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.7.4 Ceva Sante Animale Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.7.5 Ceva Sante Animale Recent Developments
- 12.8 CZ Vaccines S.A.U. (Zendal Health S.A.)
- 12.8.1 CZ Vaccines S.A.U. (Zendal Health S.A.) Company Information
- 12.8.2 CZ Vaccines S.A.U. (Zendal Health S.A.) Business Overview
- 12.8.3 CZ Vaccines S.A.U. (Zendal Health S.A.) Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.8.4 CZ Vaccines S.A.U. (Zendal Health S.A.) Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.8.5 CZ Vaccines S.A.U. (Zendal Health S.A.) Recent Developments
- 12.9 Indian Immunologicals Ltd. (National Dairy Development Board)
- 12.9.1 Indian Immunologicals Ltd. (National Dairy Development Board) Company Information
- 12.9.2 Indian Immunologicals Ltd. (National Dairy Development Board) Business Overview
- 12.9.3 Indian Immunologicals Ltd. (National Dairy Development Board) Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.9.4 Indian Immunologicals Ltd. (National Dairy Development Board) Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.9.5 Indian Immunologicals Ltd. (National Dairy Development Board) Recent Developments
- 12.10 Vaxxinova International BV (EW Group)
- 12.10.1 Vaxxinova International BV (EW Group) Company Information
- 12.10.2 Vaxxinova International BV (EW Group) Business Overview
- 12.10.3 Vaxxinova International BV (EW Group) Revenue in Pharmaceutical Microbiology Rapid Testing Business (2021-2026)
- 12.10.4 Vaxxinova International BV (EW Group) Pharmaceutical Microbiology Rapid Testing Product Portfolio
- 12.10.5 Vaxxinova International BV (EW Group) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst